Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REACTION Trial: Souvenaid in Cognitive Aging
NCT04147624Phase 2Completed
- Sponsor
- University of Miami
- Start
- Jun 2021
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in No canonical disease name; "cognitive deterioration" is a descriptive term, not a recognized disease entity, sponsored by University of Miami. Primary endpoints: Successful recruitment rate, Successful recruitment time and 1 more. Started Jun 2021; status: completed.
02
Conditions
No canonical disease name; "cognitive deterioration" is a descriptive term, not a recognized disease entity.
Beyond the preview
Go deeper on NCT04147624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04147624.